Vasorelaxant activity of Euphorbia furcillata Kunth mainly by activation of NO/cGMP pathway and calcium channel blockade by Sánchez-Recillas, Amanda et al.
  
          BOLETÍN LATINOAMERICANO Y DEL CARIBE 
            DE PLANTAS MEDICINALES Y AROMÁTICAS 
          17 (3): 310 - 323 (2018) 
                              © / ISSN 0717 7917 / www.blacpma.usach.cl 
  
Artículo Original | Original Article 
310 
 
Vasorelaxant activity of Euphorbia furcillata Kunth mainly by activation 
of NO/cGMP pathway and calcium channel blockade 
  
[Actividad vasorrelajante de Euphorbia furcillata Kunth principalmente por activación de la  
vía NO/GMPc y bloqueo de canales de calcio] 
 
Amanda Sánchez-Recillas1, Jesus A. Araujo-León2, Laura Rivero-Medina1, Hermenegilda Moreno-Diaz3,  
Ana S. Antonio-de-la-Cruz3 & Rolffy Ortiz-Andrade1 
 
1Laboratorio de Farmacología, Facultad de Química, Universidad Autónoma de Yucatán, Mérida, Yucatán, México 
2Laboratorio de Cromatografía, Facultad de Química, Universidad Autónoma de Yucatán, Yucatán, México 
3Instituto de Química Aplicada, Universidad del Papaloapan, Tuxtepec, Oaxaca, Mexico. 
Contactos | Contacts: Rolffy ORTIZ-ANDRADE - E-mail address: rolffy@correo.uady.mx 
 
 
Abstract: The aim of current study was to determinate ex vivo and chromatographic fingerprint by HPLC of four extracts of Euphorbia 
furcillata K. Ethyl acetate extract of Euphorbia furcillata (EaEEf) was the most effective and potent extract (Emax=98.69±1.24%) and its 
effect was partially endothelium-dependent. Functional vasorelaxant mechanism of action of EaEEf was determinate, EaEEf showed 
efficient relaxation of KCl [80 mM]-induced contraction and norepinephrine and CaCl2 contraction curves showed diminution of maximal 
contraction in the presence of EAEEf and EaEEf-relaxation curve was shifted to the right in the presence of L-NAME  (nitric oxide synthase 
inhibitor) and ODQ (guanylate cyclase inhibitor). Chromatographic fingerprints analysis suggests presence of diterpenoid such as abietane, 
tigliane, and ingenane skeletons. Our experiments suggest the EaEEf vasorelaxant activity could be attributed to diterpenoid molecules 
whose mechanism involves nitric oxide production and calcium channel blockade. 
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Resumen: Se determinó el efecto vasorrelajante ex vivo y los perfiles cromatográficos mediante HPLC de cuatro extractos de Euphorbia 
furcillata K.. El extracto de acetato de etilo de E. furcillata (EaEEf) fue el más eficaz y potente en la contracción inducida por norepinefrina 
(Emax=98.69±1.24%) y el efecto fue parcialmente dependiente del endotelio vascular. Se determinó el mecanismo de acción vasorrelajante 
para EaEEf, este mostró ser eficaz sobre la contracción inducida por KCl [80 mM] y la curva de contracción en respuesta a norepinefrina y 
CaCl2 en presencia de EaEEf mostró disminución en la contracción máxima, mientras que la curva de relajación de EaEEf en presencia de 
L-NAME (inhibidor de óxido nítrico sintasa) y ODQ (inhibidor de guanilato ciclasa) se desplazó hacia la derecha. El análisis 
cromatográfico de EaEEf sugiere la presencia de moléculas diterpenoides como abietano, tigliano y esqueletos de ingenano. Nuestros 
resultados sugieren que el efecto vasorrelajante de EaEEf podría atribuirse a moléculas diterpenoides, cuyo mecanismo de acción involucra 
la producción de óxido nítrico y bloqueo de canales de calcio. 
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INTRODUCTION 
Plants have been utilized as medicines for thousands 
of years (Samuelsson, 2004) and remain today as an 
important source of treatment for nearly 80% of the 
world population (Jiménez, 2005). Their use has led 
to the isolation and characterization of active 
compounds that represent novel candidates for the 
development of phytomedicines, which can be used 
to treat chronic, degenerative, and infectious diseases 
with high prevalence in the world population 
(Mouhssen, 2013). Thus, more recently, drug 
discovery techniques have been applied to the 
standardization of herbal medicines (Butler, 2004). 
Cardiovascular diseases are the cause of one 
third of the total amount of deaths worldwide. In 
Mexico, the prevalence of this disease has remained 
stable, affecting 30–35% of the population since 2006 
according to the National Health and Nutrition 
Survey (Barquera et al., 2010). Due to the wide 
diversity and cultural inheritance of the country, 
Mexican traditional medicine has developed 
therapeutic strategies through the use of medicinal 
plant preparations. This knowledge is commonly 
utilized to provide alternative treatments to the 
existing drugs employed for hypertension or to 
contribute to the improvement of the lifestyle of 
patients with hypertension (Heinrinch, 2003). 
There are many plant species used in 
Mexican traditional medicine and the majority of 
these belong to the Anacardiaceae, Apocynaceae, 
Asteraceae, Burseraceae, Cactaceae, Euphorbiaceae, 
Fabaceae, Malpighiaceae, and Rubiaceae families 
(Monroy-Ortiz & Castillo-España, 2007). Euphorbia 
furcillata Kunth, commonly known as “hierba del 
coyote” (coyote grass), belongs to the most important 
genus of the Euphorbiaceae family, Euphorbia.  
Euphorbia furcillata Kunth is utilized in traditional 
medicine for the treatment of diabetes, rheumatic and 
non-rheumatic pain, infertility, inflammation, and 
hypertension (Martínez et al., 2002). There are few 
systematic studies that support the therapeutic use of 
this medicinal plant; however, some studies report 
that other species from the Euphorbia genus present 
many pharmacological effects such as protection 
against nociceptive pain and inflammation (Ding et 
al., 2016) in an in vitro arthritis model (Palit et al., 
2016), apoptosis mediated cytotoxicity in intestinal 
epithelial cells of rats (Gao et al., 2015) and Human 
Epidermoid carcinoma strain cells (Betancur-Galvis 
et al., 2002), as well as apoptosis and autophagy 
mediated cytotoxicity in HeLa human cervical 
carcinoma cells, and MDA-MB-231 and MCF-7 
breast tumor cells (Lu et al., 2008; Gao et al., 2016). 
In addition, antibacterial (Elumalai et al., 2010; 
Mohsenipour & Hassanshahian, 2016), antidiabetic 
(Sunil et al., 2010; Pooja et al., 2011; Rahmatullah et 
al., 2012; Mansuri & Patel, 2013), antioxidant 
(Kumar et al., 2010), vasorelaxant (Wang et al., 
2013), anti-parasitic (Amin et al., 2016), anti-fungal 
(Rawal et al., 2014; Xu et al., 2015) anti-viral (Zheng 
et al., 1998; Betancur-Galvis et al., 2002; Ávila et al., 
2010; Zhao et al., 2014), anti-inflammatory (Xu et 
al., 2012; Liu et al., 2014), antidiarrheic (Gálvez et 
al., 1993), and multidrug resistance-modulating 
effects are reported (Jiao et al., 2015; Rédei et al., 
2015). 
Previous phytochemical studies reveal that 
terpenoids, coumarins, lignans, alkaloids, flavones, 
flavonoids, and glycosides have been isolated from 
the genus Euphorbia (Shi et al., 2008; Vasas & 
Hohmann, 2014; Rédei et al., 2015; Sheliya et al., 
2015; Li et al., 2015; Nguyen et al., 2016).  
The current study aimed to investigate the 
vasorelaxant effect and mode of action of Euphorbia 
furcillata Kunth in an ex vivo test. Additionally, the 
chromatographic fingerprints of E. furcillata extracts 
were determined. 
 
MATERIAL AND METHODS 
Chemicals and drugs 
(+/-)-norepinephrine bitartrate hydrate (NE), 
carbamoylcholine chloride (carbachol), 
indomethacin, L-NG-nitroarginine methyl ester (L-
NAME), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-
one (ODQ), potassium chloride (KCl), calcium 
chloride (CaCl2), and dimethylsulfoxide (DMSO) 
were purchased from Sigma-Aldrich Co. (St. Louis, 
MO, USA). All other reagents and solvents were 
analytical grade and obtained from local sources. 
Stock extracts were prepared with distilled water on 
the same day of experimentation. The methanol 
(Fermont, México) was used in the chromatographic 
analysis was of chromatographic grade. Deionized 
water was purified by an E-pure water purification 
system (Thermo Scientific). As internal standard to 
establish the relative retention time, we used flavone 
(Sigma-Aldrich), analytical grade. 
 
Plant material and extraction 
Aerial parts of Euphorbia furcillata Kunth (coyote 
grass) were collected at a Mixtec region, Luz Nagore, 
Huajuapan de León, Oaxaca, Mexico, in March, 
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2016. E. furcillata K. was identified and voucher 
specimen was deposited (voucher in process) at the 
Herbarium, Oaxaca, Mexico. 
The leaves of the plant were separated, 
washed whit water, dried to room temperature (25º 
C), and crushed in an industrial blender. Then, the 
powdered leaves (673 g) were subjected to successive 
maceration processes utilizing hexane (5.0 L), 
dichloromethane (3.4 L), ethyl acetate (4.5 L), and 
finally methanol (2.7 L) with three solvent changes 
every 72 h. After filtration, organic extracts were 
concentrated in vacuum at 40º C using a Rotavapor 
(Buchi® R-200) and the percentages of the yields 
obtained were as follows: Hexanic Extract (HEEf): 
2.6%; Dichloromethane Extract (DEEf): 0.95%; 
Ethyl acetate Extract (EaEEf): 3.65%, and 
Methanolic Extract (MEEf), 5.24%, respectively. 
 
Chromatographic fingerprints of E. furcillata 
extracts 
An Agilent Technologies 1200-series HPLC system 
(Agilent, San Jose, CA, USA) with a quaternary 
pump and a UV-DAD detector equipped with a 
Zorbax Eclipse Plus C18 column (250 mm × 4.6 mm 
i.d., 5 μm, Agilent, USA) was employed. 
Chromatography was performed under gradient 
conditions with H2O: MeOH with a mobile-phase 
flow rate of 1.5 mL/min and with the injection of 5 
μL of the sample. The column was purged with the 
mobile phase for 10 min, followed by equilibration 
for 10 min. Total time required for sample analysis 
was 40 min. Spectral data were collected and plotted 
at detection wavelengths of 280 nm. 
 
Pharmacological evaluation 
Animals 
Adult male Wistar rats (250–300 g bodyweight) were 
obtained from the Animal House of Centro de 
Investigaciones Regionales “Dr. Hideyo Noguchi” of 
the Universidad Autonóma De Yucatán (UADY), 
Mexico. Animals were housed in polycarbonate 
cages and maintained under standard laboratory 
conditions (12-h light/dark cycle, at a temperature of 
25 ± 2º C, and with a humidity of 45–65%), and were 
fed with standard rodent diet and water ad libitum. 
All animal procedures were conducted in accordance 
to our Federal Regulations for Animal 
Experimentation and Care (SAGARPA, NOM-062-
ZOO-1999, México) and approved by the 
Institutional Animal Care and Use Committee. All 
experiments were carried out using six animals per 
group. All study animals were euthanized by cervical 
dislocation after deep anesthesia with ether. 
 
General procedures  
Rats were euthanized by cervical dislocation and 
thoracic dissection was carried out to extract the 
thoracic aorta. The latter was cleaned from adjacent 
and connective tissue and then cut into strips 3 mm in 
length. In addition, for some aortic rings, the 
endothelium layer was gently removed by manual 
procedures. Then, the tissue sections were assembled 
using stainless steel hooks under an optimal tension 
of 3 g and were allowed to stabilize for 20 min in 
chambers at 37° C containing Krebs–Henseleit 
Solution (KHS; composition, mM: NaCl, 119; KCl, 
4.6; KH2PO4, 1.2; MgSO4, 1.2; CaCl2, 1.5; NaHCO3, 
20; EDTA, 0.026, and glucose, 11.4; pH 7.4) 
constantly bubbled with an O2:CO2 (95:5) mixture. 
Tension changes were recorded by Grass-FT03 force 
transducers (Astro Med, West Warwick, RI, USA) 
connected to an MP150 analyzer (BIOPAC 4.1 
Instruments, Santa Barbara, CA, USA) as described 
previously by Estrada-Soto et al. (2010). 
After the stabilization period, sensibilization 
was carried out. The tissues were stimulated with 
Noradrenaline (NE [0.1 μM]) during 15 min, washed 
with fresh KHS, and allowed to stabilize for 15 min. 
This procedure was repeated three times. The absence 
of endothelium was confirmed by the lack of the 
relaxant response induced by carbachol (CCH [1 
μM]) in the last contraction with NE prior to washing 
with fresh KHS to assess viability. 
 
Vasorelaxant effect of extracts, controls, and vehicle 
on the contraction induced by NE  
After sensibilization, tissues were allowed to stabilize 
for 20 min and then, these were contracted with NE 
[0.1 μM]. Extracts [3.03–1000 μg/mL], vehicle 
[100% final concentration] or positive controls (CCH 
for endothelium-intact aortic rings, E+ [0.303–100 
μg/mL] or Nifedipine for endothelium-denuded aortic 
rings, E-, [3.89 × 10-5–3.46 μg/mL]) were added to 
the chamber in cumulative concentrations 
[Concentration–Response Curves (CRC)]. The 
relaxant effect of the samples was determined by 
their ability to reduce the maximal vascular 
contraction induced by NE, comparing tissue tension 
before and after its addition. 
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Determination of the EaEEf mode of action 
In order to establish the EaEEf mode of action, the 
following experiments were conducted: 
a) To establish a possible antagonism of 
adrenergic receptor or disruption of the NE 
pathway, the following procedures were 
performed on endothelium-denuded aortic 
rings. A cumulative NE-induced contraction 
[1.15 × 10-11 to 1.00 × 10-5 M] CRC was built 
and established as positive control (control 
CRC). In another experiment, aortic rings 
were pre-incubated with EaEEf (median 
Effective Concentration [EC50 = 145 μg/mL]) 
for 15 min, and then, the CRC to NE-induced 
contraction was performed to compare the 
NE-induced contraction in the absence and 
presence of EaEEf. 
b) In order to know the role of endothelium-
derived relaxing factors such as nitric oxide 
(NO) or rostacyclin (PGI2), endothelium-
intact aortic rings were pre-incubated with 
NG-nitro-L-arginine methyl ester (L-NAME, 
a nitric oxide synthase (NOS) inhibitor, [100 
μM]) or indomethacin (a cyclooxygenase 
(COX) unspecific inhibitor, [10 μM]), 
respectively, for 15 min prior to contraction 
with NE [0.1 μM]. The relaxation CRC of 
EaEEf [3.03 - 1000 μg/mL] was built as 
described in the vasorelaxant set of 
experiments. The maximal relaxing effect of 
EaEEf was compared in the absence and 
presence of L-NAME or Indomethacin.  
c) To establish the possible inhibition of the 
soluble guanylyl cyclase enzyme (sGC), 
endothelium-intact aortic rings were pre-
incubated with 1-H-[1,2,4]-oxadiazolo-
[4,3a]-quinoxalin-1-one (ODQ, an sGC 
inhibitor, [10 μM]) for 15 min prior to the 
contraction with NE [0.1 μM]. The relaxation 
CRC of EaEEf [3.03 - 1000 µg/mL] was built 
as described previously. The maximal 
relaxing effect of EaEEf was compared in the 
absence and presence of ODQ. 
d) In order to know the role of K+ channels in 
the extract-induced vasorelaxant effect, 
intact-endothelium aortic rings were pre-
incubated with tetraethylammonium (TEA, a 
non-selective KCa2+ channel blocker [10 
μM]) for 15 min prior to the contraction with 
NE [1 μM]. The relaxation CRC of EaEEf 
[3.03 - 1000 µg/mL] was built as described 
previously. The maximal relaxing effect of 
EaEEf was compared in the absence and 
presence of TEA. 
 
e) To determine whether inhibition of 
extracellular Ca2+ influx was involved in the 
extract-induced vasorelaxation, the 
experiments were carried out in Ca2+-free 
KHS. Endothelium-denuded aortic rings were 
washed with Ca2+-free KHS containing KCl 
[80 mM] after sensibilization and were 
allowed to stabilize for 15 min. Then, a CRC 
for the CaCl2-induced contraction was 
obtained in the absence of EaEEf (control 
group). Once the maximal contraction was 
reached, tissue was washed with Ca2+-free, 
KCl [80 mM] KHS and allowed to stabilize 
for 20 min. Finally, after a 15-min incubation 
with the EaEEf [EC50= 45 μg/mL], another 
CRC for the CaCl2-induced contraction was 
obtained. The contractile effect induced by 
CaCl2 was compared in the absence and 
presence of EaEEf.  
 
Data analysis 
Results are expressed as the mean (n = 5) ± Standard 
Error of the Mean (S.E.M). Concentration–Response 
Curves (CRC) were plotted, and the experimental 
data from the CRC were adjusted by the nonlinear 
Hill equation with a curve-fitting program ORIGIN 
8.0 and were calculated pharmacological parameters 
[efficacy (Emax) and median Effective Concentration 
(EC50) values]. The statistical significance of 
differences between means was assessed by a one-
way analysis of variance (ANOVA) followed by the 
Tukey post hoc test; p values <0.05 (*p<0.05) were 
considered statistically significant (Bailey, 1995; 
Daniel, 2002). 
 
RESULTS 
Pharmacological Evaluation  
Aerial parts of Euphorbia furcillata were subjected to 
extraction by maceration: the extract with the highest 
yield was the methanolic extract (MEEf, 5.24%), 
followed by the Ethyl acetate Extract (EaEEf, 
3.65%), the hexanic extract (HEEf, 2.6%), and the 
Dichloromethane Extract (DEEf, 0.95%). HEEf, 
DEEf, EaEEf, and MEEf were evaluated using aortic 
rings pre-contracted with NE to determine their 
potential activity as vasorelaxant agents and their 
mode of action. Additionally, we determined the 
Sanchez-Recillas et al. Vasorelaxant activity of Euphorbia furcillata Kunth 
 
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/314 
 
chromatographic fingerprints of the Euphorbia furcillata extracts.  
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Figure No. 1 
Concentration-response curves of vasorelaxant effect from Euphorbia furcillata K. extracts A) HEEf, B) 
DEEf, C) EaEEf, and D) MEEf. Results are expressed as the means ± SEM of six experiments, *p<0.05 
represents significant difference compared with endothelium-absence aortic rings. 
 
Results showed that EaEEf was the most effective 
and potent extract (Emax= 98.69 ± 1.24%; EC50 = 145 
μg/mL) (Figure No. 1C) in endothelium-intact 
vascular relaxation compared with HEEf (Emax = 
74.13 ± 6.21%; EC50 = 667.21 μg/mL) (Figure No. 
1A), DEEf (Emax = 67.27 ± 8.25%; EC50 = 473.06 
μg/mL) (Figure No. 1B), and MEEf (Emax = 54.16 ± 
4.64%; EC50 = 909.51 μg/mL) (Figure No. 1D) and 
was also more effective than positive control 
(Carbachol: Emax = 75%) (Figure No. 1C). The 
vasorelaxant effect showed by four organic extracts 
was concentration- and partially endothelium-
dependent (Figure No. 1A & 1D). Table No. 1 
depicts the pharmacological parameters (Emax and 
EC50) obtained for the extracts and positive controls 
employed. EaEEf was more potent and efficient in 
both endothelium-intact and endothelium-denuded 
vascular relaxation in aorta ring assays, 
demonstrating a vasorelaxant effect that was partially 
endothelium-dependent; thus, its possible functional 
mode of action was assessed. To investigate the 
possible adrenergic receptors antagonism or the 
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disruption of the NE-Ca2+ intracellular increase 
pathway, endothelium-denuded aortic rings were pre-
incubated with EaEEf followed by a NE-induced 
contraction curve, and the maximal contractile effect 
induced by NE was compared in the absence (Emax = 
4.17 ± 0.16 g, control curve) and presence of EaEEf. 
As a result, during pre-incubation with the EaEEf 
assay, the CRC showed significant reduction of NE-
induced maximal contraction (Emax = 0.48 ± 0.46 g) 
(Figure No. 2A).  
 
Table No. 1 
Pharmacological parameters of vasorelaxant effect of Euphorbia furcillata Kunth extracts and controls 
Extract Aortic rings  
endothelium-intact (E+) 
Aortic rings  
without-endothelium (E-) 
 Emax (%) EC50 (g/mL) Emax (%) EC50 (g/mL) 
Carbachol 
(Control, E+) 
75±2.75 0.11±0.03 - - 
Nifedipine 
(control, E-) 
- - 100±4.38 0.012±0.014 
HEEf 74.13±6.21 610.90±6.81 53.02±6.09 979.14±6.09 
DEEf 67.27±8.25 473.06±6.22 51.07±6.60 957.56±6.60 
EaEEf 98.69±1.24 145.06±4.56 73.16±5.66 614.62±6.80 
MEEf 54.16±4.64 909.51±4.01 11.47±1.72 >1000* 
Emax: maximum effect, EC50: Effective concentration medium, HEEf: Hexanic extract of 
Euphorbia furcillata Kunth, DEEf: Dichloromethane extract of Euphorbia furcillata Kunth, 
EaEEf: Ethyl acetate extract of Euphorbia furcillata Kunth, MEEf: methanolic extract of 
Euphorbia furcillata Kunth. 
*Parameter not determined, since the maximum effect was less than 50% 
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Figure No. 2 
Concentration-response curves (CRC) contraction to A) Norepinephrine and B) CaCl2 C) CRC of EaEEf-
induced relaxation to KCl (80 mM)-induced contraction. *p<0.05 represents significant difference compared 
with control. 
 
 
To assess whether Ca2+ channel blockade was 
involved in the vasorelaxant effect of EaEEf, a 
contraction curve with CaCl2 was obtained (control); 
the maximal contractile effect induced by CaCl2 was 
compared in the absence and presence of EaEEf. As 
result, the CaCl2-induced contraction was totally 
abolished by pre-incubation with EaEEf [145 μg/mL] 
such as nifedipine (positive control) (Figure No. 2B). 
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Moreover, the EaEEf (3.03 - 1000 μg/mL) produced a 
significant vasorelaxant effect on the KCl (80 mM)-
induced contraction (Emax = 92%) (Figure No. 2C).  
The role of K+ channels on the EaEEf-
induced vasorelaxant effect was assessed with TEA 
pre-incubation prior to contraction with NE; the 
relaxant effect of EaEEf in the presence of TEA was 
not modified (data not shown). To identify the 
participation of NO-sGC-cGMP or PGI2 –AC-cAMP 
pathways, aortic rings were pre-incubated with L-
NAME and ODQ or Indomethacin, respectively, 
prior to contraction with NE. The EaEEf relaxation 
CRC shifted to the right and decreased the maximum 
effect in the presence of L-NAME (Emax = 82.18%; 
EC50 = 428.80 μg/mL) and ODQ (Emax = 87.37%; 
EC50 = 266.16 μg/mL) in comparison to the control 
curve (Emax = 98.69 %; EC50 = 145 μg/mL) (Figure 
No. 3). While Indomethacin curve was shifted to the 
left (EC50 = 63.12 μg/mL) with respect to the control 
(EC50 = 145 μg/mL). 
The fingerprint analysis of the methanolic 
extract (MEEf) demonstrated a few signals around 
the 20-min mark in the chromatogram, identified as 
more polar according to the mobile phase elution 
(Figure No. 4A). The less polar extracts (EaEEf, 
DEEf, and HEEf) showed the same signal in the 
chromatograms. The EaEEf extract (Figure No. 4B) 
presented the majority of signals (11 signals) 
compared to the DEEf (Figure No. 4C) and the HEEf 
extract (Figure No. 4D). However, signals 15, 16, and 
17 were found in the three of these. These signals 
were found more concentrated in the EaEEf extract 
and at lowest concentration in the HEEf extract. In 
the chromatographic profile, the signals were 
observed around the 28–35-min mark, with a relative 
relation time of 1.03–1.20 min compared to the 
flavone (Figure No. 4E) (Table No. 2).  
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Figure No. 3 
EaEEf-induced relaxation concentration-response curves in presences of ODQ, L-NAME and Indomethacin. 
*p<0.05 represents significant difference compared with control 
 
 
DISCUSSION 
HEEf, DEEf, EaEEf, and MEEf were evaluated to 
determine their potential activity as vasorelaxant 
agents for the treatment of hypertension. The 
vasorelaxant effect exhibited by all organic extracts 
was concentration- and partially endothelium-
dependent, the latter suggests that Endothelium-
Derived Relaxing Factors (EDRF), such as Nitric 
Oxide (NO), Prostacyclin (PGI2), and/or the 
Endothelium-Derived Hyperpolarizing Factor 
(EDHF), are involved in extract-induced relaxation 
(Hernández-Abreu et al., 2009), as well as in 
mechanisms related to smooth-muscle-cell activity, 
such as α1-adrenoceptor antagonism, Ca2+ channel 
blockade, K+ channel opening, cyclic nucleotide 
(cAMP or cGMP) synthesis, or the Calcium-
Calmodulin complex (Ca2+ -CaM) inhibition (Huang 
& Ho, 1996; Zhang & Tan, 1998; Maciel et al., 2004; 
Zhu et al., 2007; Vergara-Galicia et al., 2010).  
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Figure No. 4 
Fingerprint analyses of Euphorbia furcillata K. extracts A) MEEf B) EaEEf C) DEEf D) HEEf and E) 
Flavone as Internal Standard from leaves part at 280 nm 
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Table No. 2 
Retention time in fingerprint analyses (n = 3) of Euphorbia furcillata Kunth 
 
Relative Retention Time 
  MEEf EaEEf DEEf HEEf 
   
Signal 
 
Retention time  
(Rt) 
Averages RSD Averages RSD Averages RSD Averages RSD 
1 6.148 0.224 0.452 N/D N/D N/D N/D N/D N/D 
2 12.543 0.457 1.203 N/D N/D N/D N/D N/D N/D 
3 12.970 0.475 0.803 N/D N/D N/D N/D N/D N/D 
4 13.008 N/D N/D 0.473 0.241 N/D N/D N/D N/D 
5 14.156 0.515 0.596 N/D N/D N/D N/D N/D N/D 
6 15.007 0.545 0.701 N/D N/D N/D N/D N/D N/D 
7 16.341 0.592 0.590 N/D N/D N/D N/D N/D N/D 
8 16.447 N/D N/D 0.604 0.695 N/D N/D N/D N/D 
9 18.711 0.685 0.498 N/D N/D N/D N/D N/D N/D 
10 20.128 N/D N/D 0.738 0.485 N/D N/D N/D N/D 
11 21.016 N/D N/D 0.766 0.718 N/D N/D N/D N/D 
12 22.369 N/D N/D 0.817 0.449 N/D N/D N/D N/D 
13 25.928 N/D N/D 0.944 0.490 N/D N/D N/D N/D 
Flavone 27.427 1.000 0.000 1.000 0.000 1.000 0.000 1.000 0.000 
14 28.089 N/D N/D N/D N/D N/D N/D 1.024 0.247 
15 28.277 N/D N/D 1.033 0.458 1.034 0.591 N/D N/D 
16 29.145 N/D N/D 1.063 0.471 1.066 0.472 N/D N/D 
17 34.775 N/D N/D 1.270 0.211 1.277 0.402 1.277 0.522 
18 36.940 N/D N/D 1.347 0.409 N/D N/D 1.347 0.422 
19 37.362 N/D N/D 1.363 0.334 N/D N/D 1.362 0.224 
20 40.572 N/D N/D N/D N/D N/D N/D 1.473 0.370 
N/D: Not Detectable, RSD: Relative standard desviation, HEEf: Hexanic extract of Euphorbia furcillata Kunth, DEEf: 
Dichloromethane extract of Euphorbia furcillata Kunth, EaEEf: Ethyl acetate extract of Euphorbia furcillata Kunth, 
MEEf: methanolic extract of Euphorbia furcillata Kunth. 
 
Because EaEEf was the more potent and 
efficient extract thus; its possible functional mode of 
action was assessed. Pre-incubation with the EaEEf 
assay, the CRC showed significant reduction of NE-
induced maximal contraction suggesting non-
competitive antagonism of adrenergic receptor or 
NE-induced contraction pathway disruption. NE 
contraction is mediated by Ca2+ intracellular increase. 
This initial transient increase in cytosolic Ca2+ 
originates from Ca2+ release from intracellular stores 
(sarcoplasmic reticulum), while the latter increase 
arises from the extracellular space through Ca2+ 
channel receptors (Hilgers & Webb, 2005). In this 
context, the contraction induced by CaCl2- was 
totally abolished by preincubation with EaEEf also 
producing a significant vasorelaxant effect on the 
KCl-induced depolarization, this behavior suggests 
blockade of L-type Ca2+ channels in smooth-muscle-
cell membrane (Hilgers & Webb, 2005). Changes in 
the intracellular Ca2+ concentration and membrane 
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depolarization stimulate large-conductance Ca2+-
activated K+ channels (BKCa), which are thought to 
play an important role in maintaining the membrane 
potential of vascular smooth muscle cells (Ko et al., 
2008). The role of K+ channels on the EaEEf-induced 
vasorelaxant effect were assessed with TEA (a non-
selective KCa2+ channel blocker) but the effect was 
not modified in the presence of TEA, suggesting that 
there is no opening of potassium channels in the 
vasorelaxant mode of action. On the other hand, 
EaEEf exhibited an endothelium-dependent effect, 
based on which we investigated the participation of 
EDRF such as NO or PGI2. To identify the 
participation of NO-sGC-cGMP or PGI2 –AC-cAMP 
pathways, aortic rings were preincubated with L-
NAME (a NOS inhibitor) or ODQ (an sGC inhibitor) 
or Indomethacin (COX inhibitor) respectively; the 
EaEEf relaxation CRC shifted to the right and 
decreased the maximum effect in the presence of L-
NAME and ODQ. The latter suggests that NO 
production and the subsequent cGMP increase might 
be involved in EaEEf-induced relaxation. 
Physiological actions of NO are mediated by 
activation of the sGC and the consequent increase in 
the concentration of cGMP. Cyclic GMP activates 
Protein Kinase G (PKG), preventing calcium influx 
through voltage-dependent calcium channels and 
calcium release mediated by Inositol 1,4,5-
triphosphate (IP3) receptors (IP3R) in vascular smooth 
muscle (Moncada et al., 1988; Ignarro, 1991). Finally 
relaxation-CRC in the presence of Indomethacin was 
shifted to the left indicating that EaEEf relaxant 
activity was synergized, but this effect may be 
attributed to the synthesis inhibition of contractile 
endogenous prostanoids, such as PGH2 (Aboulafia, 
1976; Furci et al. 1991). The fact that the 
vasorelaxant effect of EaEEf was diminished by L-
NAME and ODQ and the fact that EaEEf, as well as 
its efficiency on KCl-80-induced depolarization 
abolished CaCl2-contraction; suggest NO production 
and calcium channel blockade as the vasorelaxant 
mode of action of EaEEf. 
In the UltraViolet (UV) spectrum of MEEf, a 
highest signal of around 280–360 nm was observed, 
corresponding to flavonoid or polyphenolic 
compounds. According to Noori et al., the main 
flavonoids isolated from phytochemical studies 
performed on 17 Euphorbia species were rutin, 
quercetin, kaempferol, and myricetin, all of these 
eluting before the flavone (ISTD), indicating that 
they are more polar than this compound (Noori et al., 
2009). 
In the chromatographic profile of EaEEf 
suggest that these signals possess a high capacity 
factor in reverse- phase chromatography. According 
to Bicchi et al., some diterpenoids were isolated from 
Euphorbia seed oil, such as ingenol, hydroxylathyrol, 
and epoxylathyrol. In this work, a chromatographic 
profile of a caper spurge extract was reported that, on 
comparison to the chromatographic profile of EaEEf, 
exhibited similar signals and the same UV spectrum 
(Bicchi et al., 2001). On the other hand, Wu et al. 
(2009) reported that Euphorbia species have many 
uses in folk medicine that are attributed to 
diterpenoid constituents, especially those with 
abietane, tigliane, and ingenane skeletons..Some of 
the isolated compounds present singular 
characteristics, such as the conjugations presents in 
different rings of the structure, such as 
helioscopinolides, and epoxy, hydroxyl, and ketone 
derivatives from abietane skeleton. Tian et al. (2011) 
report there have been isolated from Ethyl acetate 
extract of different Euphorbiaceae mainly lathyrane 
diterpenoids showed significant vasorelaxant 
activities against phenylephrine-induced 
vasoconstriction, the evaluation of vasorelaxant 
activity result from its vasodilatory effects directly 
upon vascular smoot muscle with relation rates of 
48% to 53% at 10-6 M concentration (Tian et al., 
2011; Tian et al., 2013). All of these structures 
possess low polarity and eluted in the final section of 
the chromatogram (signals 15, 16, and 17) with high 
retention times.  
The signals related to the pharmacological 
effect were those with lowest polarity and highest 
retention time. Naturally occurring diterpenes exert 
several biological activities such as anti-
inflammatory action, antimicrobial and 
antispasmodic activities. Several diterpenes have 
demonstrated pronounced cardiovascular effects such 
as positive inotropic responses, activation of 
adenylate cyclase (forskolin), vasorelaxant properties 
(eleganolone and 14-deoxyandrographolide) and 
inhibition of smooth muscle contraction by blocking 
L-type calcium channels (marrubenol) (Tirapelli et 
al., 2008). As well, Bruneton (2001), reports 
antihypertensive properties of labd-8 (17) -en-15-oic 
acid and of forskolin, Ulubelen et al. (2002), 
demostrated cardiovascular activities of abietane 
diterpenes  (Bruneton, 2001; Ulubelen et al., 2002) 
and Hipólito et al. (2009), reports ability of diterpene 
ent-8(14),15-pimaradien-3beta-ol (PA-3beta-ol) to 
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induce vascular relaxation through extracellular Ca2+ 
influx blockade and by the activation of NO-cGMP 
pathway. Based in this, cardiovascular 
pharmacological effect showed by EaEEf could be 
relate with diterpenoids molecules presents in E. 
furcillata 
 
CONCLUSIONS 
To our knowledge, we have reported, for the first 
time, the cardiovascular pharmacological effect and 
chromatographic profiles of Euphorbia furcillata 
Kunth extracts. Our results, suggest that the 
vasorelaxant activity presented by the EaEEf extract 
could be attributed to diterpenoids molecules with 
abietane, tigliane, and ingenane skeletons whose 
effect involve NO production and calcium channel 
blockade as vasorelaxant mode. Our results 
contribute to pharmacological evidence of E. 
furcillata specie; however, it must be submitted to 
further in vivo studies to identify its antihypertensive 
effect. 
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